Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-132706
Filing Date
2025-06-02
Accepted
2025-06-02 06:07:30
Documents
5
Period of Report
2025-06-02

Document Format Files

Seq Description Document Type Size
1 6-K d893122d6k.htm 6-K 8672
2 EX-99.1 d893122dex991.htm EX-99.1 40695
3 GRAPHIC g893122dsp4.jpg GRAPHIC 1259
4 GRAPHIC g893122g0602103559655.jpg GRAPHIC 2601
5 GRAPHIC g893122g0602103559896.jpg GRAPHIC 3270
  Complete submission text file 0001193125-25-132706.txt   60849
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251013030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)